Indication and Approval
The only formulation available that reduces stroke risk by 37% vs. placebo
- AGGRENOX® is the only available formulation that can provide the advantages of this combination.
- AGGRENOX® is not interchangeable with the individual components of ASA and Persantine® tablets.
References
Hurwitz et al. JAMA 1997; 278 (8): 659-662.
JAMA Abstract
Boehringer Ingelheim Data on File 2002.
